Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
07/26/2012 | WO2012098219A1 Methods and kits for predicting the risk of respiratory failure, renal failure or thrombopenia in a septic patient by measuring endocan levels in blood |
07/26/2012 | WO2012098208A1 Use of stathmin as a biomarker of drug response to furazanobenzimidazoles |
07/26/2012 | WO2012098207A1 Use of bubr1 as a biomarker of drug response to furazanobenzimidazoles |
07/26/2012 | WO2012098203A1 Use of glu-tubulin as a biomarker of drug response to furazanobenzimidazoles |
07/26/2012 | WO2012098166A1 Indicator for ascertaining the state of skin |
07/26/2012 | WO2012098071A1 Medical hand-held device |
07/26/2012 | WO2012098006A1 Compounds and methods for the identification and characterization of hdac interacting compounds |
07/26/2012 | WO2012097820A1 Method and assay for predicting long-term efficacy of tamoxifen treatment in estrogen receptor-positive breast cancer patients |
07/26/2012 | WO2012097788A1 Rapid test for the qualitative and/or quantitative analysis of antibodies against human papilloma viruses (hpv) present in body fluid, and device for carrying out the rapid test |
07/26/2012 | WO2012097494A1 Blood matching unit and combiner for disposable blood transfusion and cross matching experiment |
07/26/2012 | WO2012097488A1 Calibration device for on-line sulfur hexafluoride humidity meters and calibration method therefor |
07/26/2012 | WO2012097474A1 Method and system for detecting the insertion sites of transgenic foreign fragments |
07/26/2012 | WO2012097451A1 Leukocyte activation and methods of use thereof |
07/26/2012 | WO2012097435A1 Immunoreactive francisella tularensis antigens |
07/26/2012 | WO2012097408A1 Method and apparatus for conducting an assay |
07/26/2012 | WO2012077898A3 Metabolic diseases-related odorant receptor genes and use thereof |
07/26/2012 | WO2012075506A3 Methods for predicting and treating infection-induced illnesses and predicting the severity of infection-induced illnesses |
07/26/2012 | WO2012074904A3 Methods and systems for evaluating the sensitivity or resistance of tumor specimens to chemotherapeutic agents |
07/26/2012 | WO2012074888A3 Methods and compositions for diagnosis and risk prediction in heart failure |
07/26/2012 | WO2012071199A3 Sulfur breakthrough detection assembly for use in a fuel cell system and sulfur breakthrough detection method |
07/26/2012 | WO2012061797A9 On-chip 4d lightfield microscope |
07/26/2012 | WO2012061759A3 Folate receptor alpha as a diagnostic and prognostic marker for folate receptor alpha-expressing cancers |
07/26/2012 | WO2012057548A3 Automatic real-time pcr system for the various analysis of biological smaple |
07/26/2012 | WO2012057473A3 Method for evaluating the improvement of skin elasticity using a mimetic dermis |
07/26/2012 | WO2012054555A3 Improved identification of pre-diabetes using a combination of mean glucose and 1,5-anhydroglucitol markers |
07/26/2012 | WO2012051372A3 Immunoreactive antigens of mycoplasma heamofelis and diagnostic immunoassay |
07/26/2012 | WO2012049341A3 Electronic nose having a high sensing frequency and method for determining the quantitative and qualitative composition of a gas or mixture of gases using same |
07/26/2012 | WO2012048113A3 Biomarkers of cancer |
07/26/2012 | WO2012047865A9 Electrically conductive polymer nanowires with incorporated viruses |
07/26/2012 | WO2012047325A3 N-end rule protease activity indication methods and uses thereof |
07/26/2012 | WO2012044992A9 Methods and reagents for detection and treatment of esophageal metaplasia |
07/26/2012 | WO2012039679A3 System for near-infrared autofluorescence measurement of a subject, and method thereof |
07/26/2012 | WO2012038463A3 Use of myeloid cell biomarkers for the diagnosis of cancer |
07/26/2012 | WO2012031752A3 Tuberculosis mutants |
07/26/2012 | WO2012030756A4 Method and system for measuring nasal resistance to airflow |
07/26/2012 | WO2012030196A9 Oligonucleotide marker and method for identifying the same |
07/26/2012 | WO2012013607A3 Device for determining properties of a fluid by means of a coaxial resonator shorted at one end by a plate through which the fluid flows |
07/26/2012 | US20120192315 Resistance genes and proteins active against fusarium root rots, cyst nematodes and soybean sudden death syndrome and methods employing same |
07/26/2012 | US20120192297 Screening method utilizing thalidomide-targeting factor |
07/26/2012 | US20120192296 Preparation of isolated agonist anti-edar monoclonal antibodies |
07/26/2012 | US20120192295 Composition comprising extracellular membrane vesicles derived from indoor air, and use thereof |
07/26/2012 | US20120192294 Inhibitors of the Nitration of Amyloid Beta Peptides and Their Uses in the Diagnosis and Treatment of Alzheimer's Disease |
07/26/2012 | US20120191362 Calibration method for the prospective calibration of measuring equipment |
07/26/2012 | US20120191361 Tracking the Probability for Imminent Hypoglycemia in Diabetes From Self-Monitoring Blood Glucose (SMBG) Data |
07/26/2012 | US20120191360 CSF biomarker dilution factor corrections by MRI imaging and algorithm |
07/26/2012 | US20120191355 Insect Prediction Techniques for the Forestry Industry |
07/26/2012 | US20120191009 Method and apparatus for in vivo surveillance of circulating biological components |
07/26/2012 | US20120190950 Electrode compositions for use with analyte sensors |
07/26/2012 | US20120190821 Recombinant soluble fc receptors |
07/26/2012 | US20120190734 Compounds and compositions for treating infection |
07/26/2012 | US20120190727 Method and means for treatment of osteoarthritis |
07/26/2012 | US20120190627 Cosmetic use of lacritin-type polypeptides |
07/26/2012 | US20120190620 Methods to identify targets and molecules regulating purinosomes and their uses |
07/26/2012 | US20120190619 Methods of identifying anti-inflammatory compounds |
07/26/2012 | US20120190589 Assay Cartridges and Methods of Using the Same |
07/26/2012 | US20120190586 Synthetic Receptors for Identification of Protein Posttranslation Modifications |
07/26/2012 | US20120190585 Concurrent optimization in selection of primer and capture probe sets for nucleic acid analysis |
07/26/2012 | US20120190581 Detection of Auto-Antibodies to Specific Glycans as Diagnostic Tests for Autoimmune Diseases |
07/26/2012 | US20120190580 Treatment of patients after stent implantation or balloon dilatation and drug eluting stents |
07/26/2012 | US20120190579 Functionalisation of Solid Substrates |
07/26/2012 | US20120190578 Plasma Complement Components as Expression Markers for Age-Related Macular Degeneration and Related Phenotypes |
07/26/2012 | US20120190573 Biomarker of lung cancer |
07/26/2012 | US20120190570 Molecular targets and compounds, and methods to identify the same, useful in the treatment of joint degenerative and inflammatory diseases |
07/26/2012 | US20120190569 Endogenetic retroviral sequences, associated with autoimmune diseases or with pregnancy disorders |
07/26/2012 | US20120190568 Genetic markers associated with age-related macular degeneration, methods of detection and uses thereof |
07/26/2012 | US20120190566 Compositions and methods for inhibiting biofilms |
07/26/2012 | US20120190565 Method Of Diagnosis Or Prognosis Of A Neoplasm Comprising Determining The Level Of Expression Of A Protein In Stromal Cells Adjacent To The Neoplasm |
07/26/2012 | US20120190564 Identification of protein binding sites |
07/26/2012 | US20120190563 Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor |
07/26/2012 | US20120190561 Means and methods for diagnosing endometriosis |
07/26/2012 | US20120190560 Method for automated, large-scale measurement of the molecular flux rates of the proteome or the organeome using mass spectrometry |
07/26/2012 | US20120190558 Schizophrenia-related isoform of kcnh2 and development of antipsychotic drugs |
07/26/2012 | US20120190132 Device and method of monitoring a patient |
07/26/2012 | US20120190130 Cartridge for detecting target antigen and method for detecting target antigen using the same |
07/26/2012 | US20120190129 Test device, reaction apparatus and reactive test method |
07/26/2012 | US20120190119 Method and system for modulating substances in the formation vitamins |
07/26/2012 | US20120190058 Method for evaluating cell populations |
07/26/2012 | US20120190056 Encoded Microparticles |
07/26/2012 | US20120190051 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
07/26/2012 | US20120190050 Cancer biomarker and the use thereof |
07/26/2012 | US20120190049 Glypican-3 targeting of liver cancer cells using multifunctional nanoparticles |
07/26/2012 | US20120190048 Method for determining the binding of a given compound to a membrane receptor |
07/26/2012 | US20120190047 Levetiracetam Immunoassays |
07/26/2012 | US20120190046 DEK as a urine based biomarker for bladder cancer |
07/26/2012 | US20120190045 Peptide Inhibitors of ABL Kinases |
07/26/2012 | US20120190044 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
07/26/2012 | US20120190043 Enzymatic substrates for multiple detection systems |
07/26/2012 | US20120190042 Protein biomarkers and therapeutic targets for osteoarthritis |
07/26/2012 | US20120190041 Methods, immunoassays and devices for detection of anti-lipoidal antibodies |
07/26/2012 | US20120190040 Cell concentration, capture and lysis devices and methods of use thereof |
07/26/2012 | US20120190039 Raf dimers and uses thereof |
07/26/2012 | US20120190029 Methods for detecting dna originating from different individuals |
07/26/2012 | US20120190017 Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications |
07/26/2012 | US20120190013 Hydrolase enzyme substrates and uses thereof |
07/26/2012 | US20120190006 Optoelectronic detection system |
07/26/2012 | US20120189746 Stirring apparatus for cooking vessel |
07/26/2012 | US20120189745 Stirring apparatus for cooking vessel |
07/26/2012 | US20120189663 Method of producing a medical composition |
07/26/2012 | US20120189662 Identification of virulence associated regions RD1 and RD5 leading to improve vaccine of M. bovis BCG and M. microti |
07/26/2012 | US20120189640 Methods and Compositions Related to Soluble Monoclonal Variable Lymphocyte Receptors of Defined Antigen Specificity |